Finanzen von DIH Holding US Inc (DHAI)DHAIDIH Holding US Inc

DIH Holding US Inc (DHAI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Devices, accounting for 78.5% of total sales, equivalent to $10.34M. Other significant revenue streams include Services and Other. Understanding this composition is critical for investors evaluating how DHAI navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, DIH Holding US Inc maintains a gross margin of 47.17%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -25.36%, while the net margin is -34.82%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively DHAI converts its operational activities into shareholder value.

In the context of the broader market, DHAI competes directly with industry leaders such as BBLG and VERO. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, DHAI's gross margin of 47.17% stands against BBLG's N/A and VERO's 64.00%. Such benchmarking helps identify whether DIH Holding US Inc is trading at a premium or discount relative to its financial performance.